Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q66360854 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000044.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q66360854 | ||
| 035 | ‡a (OCoLC)Q66360854 | ||
| 100 | 0 | ‡a Katrin Anne Becker ‡c researcher ‡9 en | |
| 670 | ‡a Author's A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression | ||
| 670 | ‡a Author's Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death | ||
| 670 | ‡a Author's Acid sphingomyelinase | ||
| 670 | ‡a Author's Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs | ||
| 670 | ‡a Author's Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis | ||
| 670 | ‡a Author's Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis | ||
| 670 | ‡a Author's Bacterial infections and ceramide | ||
| 670 | ‡a Author's Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System | ||
| 670 | ‡a Author's Ceramide-enriched membrane domains in infectious biology and development | ||
| 670 | ‡a Author's Ceramide-enriched membrane domains--structure and function | ||
| 670 | ‡a Author's Ceramide in bacterial infections and cystic fibrosis | ||
| 670 | ‡a Author's Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis | ||
| 670 | ‡a Author's Ceramide in redox signaling and cardiovascular diseases | ||
| 670 | ‡a Author's CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa | ||
| 670 | ‡a Author's Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm | ||
| 670 | ‡a Author's Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice | ||
| 670 | ‡a Author's Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway | ||
| 670 | ‡a Author's Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs | ||
| 670 | ‡a Author's Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. | ||
| 670 | ‡a Author's Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells | ||
| 670 | ‡a Author's Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons | ||
| 670 | ‡a Author's Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis | ||
| 670 | ‡a Author's Lipids in cystic fibrosis | ||
| 670 | ‡a Author's Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets | ||
| 670 | ‡a Author's Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine | ||
| 670 | ‡a Author's Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. | ||
| 670 | ‡a Author's Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. | ||
| 670 | ‡a Author's Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase | ||
| 670 | ‡a Author's Regulation of Arthritis Severity by the Acid Sphingomyelinase | ||
| 670 | ‡a Author's Regulation of hematogenous tumor metastasis by acid sphingomyelinase | ||
| 670 | ‡a Author's Regulation of the inflammasome by ceramide in cystic fibrosis lungs. | ||
| 670 | ‡a Author's Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor Metastasis | ||
| 670 | ‡a Author's Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa | ||
| 670 | ‡a Author's Sphingolipids as targets for inhalation treatment of cystic fibrosis. | ||
| 670 | ‡a Author's Sphingosine's role in epithelial host defense: A natural antimicrobial and novel therapeutic | ||
| 670 | ‡a Author's Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide | ||
| 670 | ‡a Author's Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides | ||
| 670 | ‡a Author's Targeting a mitochondrial potassium channel to fight cancer | ||
| 670 | ‡a Author's Targeting the ceramide system in cancer | ||
| 670 | ‡a Author's Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells | ||
| 670 | ‡a Author's The ceramide system as a novel antidepressant target. | ||
| 670 | ‡a Author's The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis | ||
| 919 | ‡a inhibitionofacidsphingomyelinaseallowsforselectivetargetingofcd4+conventionalversusfoxp3+regulatorytcells ‡A Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells ‡9 1 | ||
| 919 | ‡a lackofsphingosinecausessusceptibilitytopulmonarystaphylococcusaureusinfectionsincysticfibrosis ‡A Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis ‡9 1 | ||
| 919 | ‡a lipidsincysticfibrosis ‡A Lipids in cystic fibrosis ‡9 1 | ||
| 919 | ‡a melanomacellmetastasisviapselectinmediatedactivationofacidsphingomyelinaseinplatelets ‡A Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets ‡9 1 | ||
| 919 | ‡a neutrophilskillreactiveoxygenspeciesresistantpseudomonasaeruginosabysphingosine ‡A Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine ‡9 1 | ||
| 919 | ‡a nuclearlocalizationbutnotpmlproteinisrequiredforincorporationofthepapillomavirusminorcapsidproteinl2intoviruslikeparticles ‡A Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. ‡9 1 | ||
| 919 | ‡a nucleartranslocationofpapillomavirusminorcapsidproteinl2requireshsc70 ‡A Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. ‡9 1 | ||
| 919 | ‡a glucosylceramidecriticallycontributestothehostdefenseofcysticfibrosislungs ‡A Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs ‡9 1 | ||
| 919 | ‡a blockadeofexperimentalmultiplesclerosisbyinhibitionoftheacidsphingomyelinaseceramidesystem ‡A Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System ‡9 1 | ||
| 919 | ‡a ceramideenrichedmembranedomainsininfectiousbiologyanddevelopment ‡A Ceramide-enriched membrane domains in infectious biology and development ‡9 1 | ||
| 919 | ‡a inhibitionofacidsphingomyelinasebytricyclicantidepressantsandanalogons ‡A Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons ‡9 1 | ||
| 919 | ‡a roleofsphingolipidsandceramideinpulmonaryinflammationincysticfibrosis ‡A The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis ‡9 1 | ||
| 919 | ‡a ceramidesystemasanovelantidepressanttarget ‡A The ceramide system as a novel antidepressant target. ‡9 1 | ||
| 919 | ‡a targetingthepotassiumchannelkv13killsglioblastomacells ‡A Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells ‡9 1 | ||
| 919 | ‡a centralrolefortheacidsphingomyelinaseceramidesysteminneurogenesisandmajordepression ‡A A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression ‡9 1 | ||
| 919 | ‡a accumulationofceramideinthetracheaandintestineofcysticfibrosismicecausesinflammationandcelldeath ‡A Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death ‡9 1 | ||
| 919 | ‡a acidsphingomyelinase ‡A Acid sphingomyelinase ‡9 1 | ||
| 919 | ‡a targetingtheceramidesystemincancer ‡A Targeting the ceramide system in cancer ‡9 1 | ||
| 919 | ‡a targetingamitochondrialpotassiumchanneltofightcancer ‡A Targeting a mitochondrial potassium channel to fight cancer ‡9 1 | ||
| 919 | ‡a acidsphingomyelinaseceramidesystemmediateseffectsofantidepressantdrugs ‡A Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs ‡9 1 | ||
| 919 | ‡a gliomacelldeathinducedbyirradiationoralkylatingagentchemotherapyisindependentoftheintrinsicceramidepathway ‡A Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway ‡9 1 | ||
| 919 | ‡a engineeredliposomessequesterbacterialexotoxinsandprotectfromsevereinvasiveinfectionsinmice ‡A Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice ‡9 1 | ||
| 919 | ‡a effectsofgreenteacompoundepigallocatechin3gallateagainststenotrophomonasmaltophiliainfectionandbiofilm ‡A Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm ‡9 1 | ||
| 919 | ‡a acidsphingomyelinaseinhibitionprotectsmicefromlungedemaandlethalstaphylococcusaureussepsis ‡A Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis ‡9 1 | ||
| 919 | ‡a cftrdependentsusceptibilityofthecysticfibrosishosttopseudomonasaeruginosa ‡A CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa ‡9 1 | ||
| 919 | ‡a staphylococcusaureusαtoxininducesinflammatorycytokinesvialysosomalacidsphingomyelinaseandceramides ‡A Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides ‡9 1 | ||
| 919 | ‡a ceramideinredoxsignalingandcardiovasculardiseases ‡A Ceramide in redox signaling and cardiovascular diseases ‡9 1 | ||
| 919 | ‡a staphylococcusaureus Alpha toxindisruptsendothelialcelltightjunctionsviaacidsphingomyelinaseandceramide ‡A Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide ‡9 1 | ||
| 919 | ‡a ceramideinpseudomonasaeruginosainfectionsandcysticfibrosis ‡A Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis ‡9 1 | ||
| 919 | ‡a sphingosinesroleinepithelialhostdefenseanaturalantimicrobialandnoveltherapeutic ‡A Sphingosine's role in epithelial host defense: A natural antimicrobial and novel therapeutic ‡9 1 | ||
| 919 | ‡a pseudomonasaeruginosapyocyanininducesneutrophildeathviamitochondrialreactiveoxygenspeciesandmitochondrialacidsphingomyelinase ‡A Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase ‡9 1 | ||
| 919 | ‡a sphingolipidsastargetsforinhalationtreatmentofcysticfibrosis ‡A Sphingolipids as targets for inhalation treatment of cystic fibrosis. ‡9 1 | ||
| 919 | ‡a ceramideinbacterialinfectionsandcysticfibrosis ‡A Ceramide in bacterial infections and cystic fibrosis ‡9 1 | ||
| 919 | ‡a sphingoidlongchainbasespreventlunginfectionbypseudomonasaeruginosa ‡A Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa ‡9 1 | ||
| 919 | ‡a ceramideenrichedmembranedomainsstructureandfunction ‡A Ceramide-enriched membrane domains--structure and function ‡9 1 | ||
| 919 | ‡a roleofacidsphingomyelinaseinducedsignalinginmelanomacellsforhematogenoustumormetastasis ‡A Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor Metastasis ‡9 1 | ||
| 919 | ‡a regulationoftheinflammasomebyceramideincysticfibrosislungs ‡A Regulation of the inflammasome by ceramide in cystic fibrosis lungs. ‡9 1 | ||
| 919 | ‡a regulationofhematogenoustumormetastasisbyacidsphingomyelinase ‡A Regulation of hematogenous tumor metastasis by acid sphingomyelinase ‡9 1 | ||
| 919 | ‡a regulationofarthritisseveritybytheacidsphingomyelinase ‡A Regulation of Arthritis Severity by the Acid Sphingomyelinase ‡9 1 | ||
| 919 | ‡a acidsphingomyelinaseinhibitorsnormalizepulmonaryceramideandinflammationincysticfibrosis ‡A Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis ‡9 1 | ||
| 919 | ‡a bacterialinfectionsandceramide ‡A Bacterial infections and ceramide ‡9 1 | ||
| 919 | ‡a identificationofadyneininteractingdomaininthepapillomavirusminorcapsidproteinl2 ‡A Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. ‡9 1 | ||
| 996 | ‡2 SIMACOB|102942563 | ||
| 996 | ‡2 DNB|130899127 | ||
| 996 | ‡2 LC|n 79099969 | ||
| 996 | ‡2 DNB|1175123293 | ||
| 996 | ‡2 DNB|172823706 | ||
| 996 | ‡2 ISNI|0000000117372976 | ||
| 996 | ‡2 SUDOC|096678755 | ||
| 996 | ‡2 CAOONL|ncf11884337 | ||
| 996 | ‡2 ISNI|0000000017223279 | ||
| 996 | ‡2 DBC|870979135895563 | ||
| 996 | ‡2 DNB|1146666640 | ||
| 996 | ‡2 DNB|173710360 | ||
| 996 | ‡2 RERO|A002982724 | ||
| 996 | ‡2 ISNI|0000000046597368 | ||
| 996 | ‡2 NUKAT|n 2007090498 | ||
| 996 | ‡2 LC|no2012033546 | ||
| 996 | ‡2 NUKAT|n 2003066368 | ||
| 996 | ‡2 SUDOC|193519208 | ||
| 996 | ‡2 DNB|130896721 | ||
| 996 | ‡2 BNF|18095365 | ||
| 996 | ‡2 ISNI|0000000081240663 | ||
| 996 | ‡2 SUDOC|061119113 | ||
| 996 | ‡2 DNB|104920025X | ||
| 996 | ‡2 XA|4369 | ||
| 996 | ‡2 ISNI|000000011499979X | ||
| 996 | ‡2 DNB|128145404 | ||
| 996 | ‡2 LC|no2012013018 | ||
| 996 | ‡2 NTA|303217162 | ||
| 996 | ‡2 LIH|LNB:B_d_LI;=BR | ||
| 996 | ‡2 DNB|1325700932 | ||
| 996 | ‡2 DNB|1015330789 | ||
| 996 | ‡2 BIBSYS|99010935 | ||
| 996 | ‡2 DNB|112111203X | ||
| 996 | ‡2 NII|DA18693563 | ||
| 996 | ‡2 DNB|123795222 | ||
| 996 | ‡2 BNF|17043917 | ||
| 996 | ‡2 RERO|A023777633 | ||
| 996 | ‡2 RERO|A006580587 | ||
| 996 | ‡2 ISNI|0000000025956237 | ||
| 996 | ‡2 DNB|130896659 | ||
| 996 | ‡2 ISNI|0000000017026523 | ||
| 996 | ‡2 ISNI|0000000459528563 | ||
| 996 | ‡2 BNF|16969784 | ||
| 996 | ‡2 ISNI|0000000014839430 | ||
| 996 | ‡2 J9U|987007330629305171 | ||
| 996 | ‡2 DNB|1162593520 | ||
| 996 | ‡2 NII|DA15408387 | ||
| 996 | ‡2 LC|n 92094993 | ||
| 996 | ‡2 DNB|132010666 | ||
| 996 | ‡2 DNB|115833270X | ||
| 996 | ‡2 DNB|1223946207 | ||
| 996 | ‡2 DNB|130896624 | ||
| 996 | ‡2 RERO|A023450646 | ||
| 996 | ‡2 DNB|131774115 | ||
| 996 | ‡2 RERO|A012608000 | ||
| 996 | ‡2 LC|n 2021010639 | ||
| 996 | ‡2 DNB|1157651348 | ||
| 996 | ‡2 DNB|124107079 | ||
| 996 | ‡2 CAOONL|ncf11418231 | ||
| 996 | ‡2 SELIBR|204047 | ||
| 996 | ‡2 LC|n 2014016336 | ||
| 996 | ‡2 DBC|87097968107040 | ||
| 996 | ‡2 DNB|133109364 | ||
| 996 | ‡2 NKC|ntk2013745615 | ||
| 996 | ‡2 NII|DA14490644 | ||
| 996 | ‡2 NKC|xx0174474 | ||
| 996 | ‡2 BNF|14430744 | ||
| 996 | ‡2 DNB|1065399960 | ||
| 996 | ‡2 BIBSYS|97025126 | ||
| 996 | ‡2 NUKAT|n 2005030632 | ||
| 996 | ‡2 NTA|383057108 | ||
| 996 | ‡2 LC|no2007141516 | ||
| 996 | ‡2 J9U|987007449304105171 | ||
| 996 | ‡2 BIBSYS|90968024 | ||
| 996 | ‡2 NKC|pna2013800858 | ||
| 996 | ‡2 DNB|1073456366 | ||
| 996 | ‡2 ISNI|0000000045825090 | ||
| 996 | ‡2 SUDOC|122886127 | ||
| 996 | ‡2 DNB|1060400170 | ||
| 996 | ‡2 BAV|495_111500 | ||
| 996 | ‡2 LIH|LNB:CO_l__d_;=B_y_ | ||
| 996 | ‡2 ISNI|0000000022083979 | ||
| 996 | ‡2 DNB|1029844208 | ||
| 996 | ‡2 NUKAT|n 2006071329 | ||
| 996 | ‡2 NII|DA06564097 | ||
| 996 | ‡2 ISNI|0000000063251596 | ||
| 996 | ‡2 NTA|068985606 | ||
| 996 | ‡2 LC|no2016137524 | ||
| 996 | ‡2 ISNI|0000000448113741 | ||
| 996 | ‡2 NUKAT|n 2017198157 | ||
| 996 | ‡2 DNB|131923129 | ||
| 996 | ‡2 NKC|mub2018994384 | ||
| 996 | ‡2 NTA|158086643 | ||
| 996 | ‡2 SUDOC|034874674 | ||
| 996 | ‡2 BNF|14154117 | ||
| 996 | ‡2 SUDOC|234419288 | ||
| 996 | ‡2 NTA|072720115 | ||
| 996 | ‡2 ISNI|0000000074501378 | ||
| 996 | ‡2 DNB|1013403002 | ||
| 996 | ‡2 BNF|14628311 | ||
| 996 | ‡2 DNB|172619297 | ||
| 996 | ‡2 DNB|10961402X | ||
| 996 | ‡2 SUDOC|176382674 | ||
| 996 | ‡2 RERO|A002983219 | ||
| 996 | ‡2 DNB|174182074 | ||
| 996 | ‡2 RERO|A025116618 | ||
| 996 | ‡2 LC|no2016044519 | ||
| 996 | ‡2 ISNI|000000010776866X | ||
| 996 | ‡2 DNB|130896675 | ||
| 996 | ‡2 ISNI|000000049775350X | ||
| 996 | ‡2 PLWABN|9810586833005606 | ||
| 996 | ‡2 DNB|1291179941 | ||
| 996 | ‡2 NUKAT|n 2006095907 | ||
| 996 | ‡2 DNB|130896594 | ||
| 996 | ‡2 ISNI|000000001696848X | ||
| 996 | ‡2 NUKAT|n 2004094454 | ||
| 996 | ‡2 ISNI|0000000458764708 | ||
| 996 | ‡2 CAOONL|ncf13771930 | ||
| 996 | ‡2 DNB|123217466 | ||
| 996 | ‡2 DNB|109472419X | ||
| 996 | ‡2 BIBSYS|1498562806775 | ||
| 996 | ‡2 LC|n 96027557 | ||
| 996 | ‡2 SUDOC|057216517 | ||
| 996 | ‡2 LC|n 84143836 | ||
| 996 | ‡2 RERO|A002982992 | ||
| 996 | ‡2 DNB|1161812261 | ||
| 996 | ‡2 BNF|17936413 | ||
| 996 | ‡2 DNB|1013444906 | ||
| 996 | ‡2 DNB|129364061 | ||
| 996 | ‡2 DNB|132088762 | ||
| 996 | ‡2 DNB|1172951586 | ||
| 996 | ‡2 ISNI|0000000077164522 | ||
| 996 | ‡2 DNB|129539457 | ||
| 996 | ‡2 NUKAT|n 2019160926 | ||
| 996 | ‡2 LC|n 92070893 | ||
| 996 | ‡2 NII|DA18988818 | ||
| 996 | ‡2 PLWABN|9810687133805606 | ||
| 996 | ‡2 DNB|130894095 | ||
| 996 | ‡2 SUDOC|057702861 | ||
| 996 | ‡2 PLWABN|9812033855705606 | ||
| 996 | ‡2 SUDOC|170300838 | ||
| 996 | ‡2 RERO|A002982981 | ||
| 996 | ‡2 BIBSYS|6087034 | ||
| 996 | ‡2 DNB|1319571832 | ||
| 996 | ‡2 DNB|1069689181 | ||
| 996 | ‡2 J9U|987007429604605171 | ||
| 996 | ‡2 SUDOC|094783543 | ||
| 996 | ‡2 LC|n 2015025394 | ||
| 996 | ‡2 LC|nb2003026714 | ||
| 996 | ‡2 BNF|12365670 | ||
| 996 | ‡2 NUKAT|n 2004258193 | ||
| 996 | ‡2 DNB|1094923559 | ||
| 996 | ‡2 DNB|143123831 | ||
| 996 | ‡2 DNB|1015064132 | ||
| 996 | ‡2 CAOONL|ncf10181767 | ||
| 996 | ‡2 DNB|1181018927 | ||
| 996 | ‡2 DNB|123751896 | ||
| 996 | ‡2 BIBSYS|15023438 | ||
| 996 | ‡2 DNB|1084652625 | ||
| 996 | ‡2 DNB|1052872638 | ||
| 996 | ‡2 DNB|1346361878 | ||
| 996 | ‡2 ISNI|0000000449256269 | ||
| 996 | ‡2 ISNI|0000000495504286 | ||
| 996 | ‡2 SUDOC|057683492 | ||
| 996 | ‡2 RERO|A011108360 | ||
| 996 | ‡2 BIBSYS|14031943 | ||
| 996 | ‡2 DNB|133254143 | ||
| 996 | ‡2 DNB|124889484 | ||
| 996 | ‡2 ISNI|0000000117433927 | ||
| 996 | ‡2 DNB|1241987149 | ||
| 996 | ‡2 DNB|124379451 | ||
| 996 | ‡2 PLWABN|9810576109205606 | ||
| 996 | ‡2 SUDOC|203115244 | ||
| 996 | ‡2 LNB|LNC10-000013558 | ||
| 996 | ‡2 DNB|1050302370 | ||
| 996 | ‡2 DNB|140310479 | ||
| 996 | ‡2 DNB|119314020X | ||
| 996 | ‡2 NDL|00942008 | ||
| 996 | ‡2 LC|n 87132582 | ||
| 996 | ‡2 NTA|091316138 | ||
| 996 | ‡2 DNB|131921487 | ||
| 996 | ‡2 LC|no2007136851 | ||
| 996 | ‡2 NTA|075017024 | ||
| 996 | ‡2 DNB|1158722745 | ||
| 996 | ‡2 DNB|1287297633 | ||
| 996 | ‡2 LC|n 2005092841 | ||
| 996 | ‡2 NTA|255847661 | ||
| 996 | ‡2 LC|no2017089238 | ||
| 996 | ‡2 BNF|13769824 | ||
| 996 | ‡2 DNB|115724887X | ||
| 996 | ‡2 DNB|1227667353 | ||
| 996 | ‡2 NTA|398118736 | ||
| 996 | ‡2 NUKAT|n 2017011083 | ||
| 996 | ‡2 LIH|LNB:V-323503;=BC | ||
| 996 | ‡2 NTA|43344648X | ||
| 996 | ‡2 NTA|158670477 | ||
| 996 | ‡2 J9U|987007359805805171 | ||
| 996 | ‡2 SIMACOB|38943331 | ||
| 996 | ‡2 DNB|131752243 | ||
| 996 | ‡2 DNB|101405866X | ||
| 996 | ‡2 LC|n 99034387 | ||
| 996 | ‡2 DNB|1112682228 | ||
| 996 | ‡2 DNB|128551836 | ||
| 996 | ‡2 ISNI|0000000449324233 | ||
| 996 | ‡2 SUDOC|190620056 | ||
| 996 | ‡2 JPG|500665844 | ||
| 996 | ‡2 DNB|1345915039 | ||
| 996 | ‡2 ISNI|0000000400043350 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
